Warby Parker Inc.

Equities

WRBY

US93403J1060

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 04:00:02 2024-04-26 pm EDT			5-day change	1st Jan Change
12.92 ^USD	+1.33%		+7.22%	-8.37%

Mar. 13	Warby Parker Insider Sold Shares Worth $290,216, According to a Recent SEC Filing	MT
Feb. 28	Warby Parker Shares Drop After Reporting Q4 Net Loss Narrows, Net Revenue Gains	MT

Warby Parker Inc. Provides Earnings Guidance for the Full Year 2024

February 28, 2024 at 06:51 am EST

Warby Parker Inc. provided earnings guidance for the full year 2024. For the year, the company expected Net revenue of $748 million to $758 million, representing approximately 12% to 13% growth versus full year 2023.

Latest news about Warby Parker Inc.

Warby Parker Insider Sold Shares Worth $290,216, According to a Recent SEC Filing	Mar. 13	MT
Warby Parker Shares Drop After Reporting Q4 Net Loss Narrows, Net Revenue Gains	Feb. 28	MT
Transcript : Warby Parker Inc., Q4 2023 Earnings Call, Feb 28, 2024	Feb. 28
Warby Parker Inc. Provides Earnings Guidance for the Full Year 2024	Feb. 28	CI
Earnings Flash (WRBY) WARBY PARKER Reports Q4 Revenue $161.9M, vs. Street Est of $160.8M	Feb. 28	MT
Warby Parker Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28	CI
Warby Parker Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 28	CI
Warby Parker Inc. and Warby Parker Retail, Inc. Terminates Prior Credit Agreement and Enters into A Credit Agreement with JP Morgan Chase Bank, N.A., Citibank, N.A. and Other Lenders	Feb. 23	CI
Morgan Stanley Adjusts Warby Parker Price Target to $13 From $12, Maintains Equal Weight Rating	Jan. 24	MT
Warby Parker Insider Sold Shares Worth $328,047, According to a Recent SEC Filing	Dec. 12	MT
Warby Parker Insider Sold Shares Worth $591,761, According to a Recent SEC Filing	Dec. 12	MT
Warby Parker Insider Sold Shares Worth $591,761, According to a Recent SEC Filing	Dec. 12	MT
Transcript : Warby Parker Inc. Presents at 2023 Morgan Stanley Global Consumer and Retail Conference, Dec-06-2023 11:00 AM	Dec. 06
Goldman Sachs Cuts Price Target on Warby Parker to $14 From $15, Keeps Neutral Rating	Nov. 10	MT
Morgan Stanley Trims Price Target on Warby Parker to $12 From $13 on Higher Weighted Average Cost of Capital, Keeps Equalweight Rating	Nov. 09	MT
Consumer Cos Down After Mixed Earnings -- Consumer Roundup	Nov. 08	DJ
Warby Parker's Q3 Adjusted Earnings Flat, Net Revenue Rises; Full-Year 2023 Revenue Outlook Raised	Nov. 08	MT
Transcript : Warby Parker Inc., Q3 2023 Earnings Call, Nov 08, 2023	Nov. 08
Earnings Flash (WRBY) WARBY PARKER Posts Q3 Revenue $169.8M, vs. Street Est of $164.6M	Nov. 08	MT
Earnings Flash (WRBY) WARBY PARKER Reports Q3 EPS $0.01, vs. Street Est of $0.01	Nov. 08	MT
Warby Parker Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 08	CI
Warby Parker Inc. Provides Revenue Guidance for the Full Year 2023	Nov. 08	CI
North American Morning Briefing : Stock Futures -2-	23-10-13	DJ
BTIG Upgrades Warby Parker to Buy From Neutral	23-10-12	MT
North American Morning Briefing : S&P 500 Futures -2-	23-10-04	DJ

Chart Warby Parker Inc.

Duration

Period

More charts

Company Profile

Warby Parker Inc. is a lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. It offers holistic vision care by selling eyewear products and providing optical services directly to consumers through its retail stores and e-commerce platform. It sells a range of prescription and non-prescription eyewear, including glasses, sunglasses, and contact lenses. Its customers can customize their prescription lenses with a variety of options, including single-vision, progressive, light-responsive, blue-light-filtering, and non-prescription lenses. It also offers in-house technologies like Virtual Vision Test and Virtual Try-On to enhance the overall customer experience. It sells its own brand of contacts, Scout by Warby Parker, and third-party contact lenses; this allows it to provide customers a vision care offering. Its Website and mobile app make it easy for its customers to browse, virtually try on, and purchase glasses.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-08 - Q1 2024 Earnings Release

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Warby Parker Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

12.92 USD

Average target price

15.17 USD

Spread / Average Target

+17.39%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Glasses, Spectacles & Contact Lenses

	1st Jan change	Capi.
WARBY PARKER INC.	-8.37%	1.54B
ESSILORLUXOTTICA	+11.95%	98.12B
ALCON INC.	+9.69%	38.82B
THE COOPER COMPANIES, INC.	-6.10%	17.66B
AUTEK CHINA INC.	-20.02%	2.24B
PEGAVISION CORPORATION	+29.63%	1.23B
MINGYUE OPTICAL LENS CO.,LTD.	-35.62%	747M
MENICON CO., LTD.	-35.36%	735M
UNIVERSAL VISION BIOTECHNOLOGY CO., LTD.	-13.36%	623M
VIZIONFOCUS INC.	+24.04%	494M

Glasses, Spectacles & Contact Lenses